The BMJ Group has retracted a controversial study on excess deaths during the COVID-19 pandemic, according to The Business Standard. The decision was made public on Wednesday, August 12, 2026, following scrutiny of the paper’s discussion section.
The study, which had been cited in a U.S. Senate hearing, was withdrawn because the journal determined that portions of its discussion contained misinformation, as reported by Retraction Watch. Scientific American noted that the paper had fueled vaccine skepticism before its retraction.
The retraction has sparked debate, with The Telegraph reporting that a row has broken out following the BMJ’s decision. Discover Magazine confirmed that the retraction was specifically tied to problematic content in the discussion portion of the research, rather than the core data or methodology.
The paper had gained attention for its claims about COVID-19 vaccines and mortality, making it a focal point in public discourse around vaccine safety. According to Retraction Watch, the study’s use in a Senate hearing added to its prominence before the journal took action.
The BMJ Group’s move reflects a broader effort by publishers to address misinformation within academic literature. The retraction does not necessarily invalidate all findings in the paper, but it signals that the journal found the discussion section to be misleading enough to warrant full withdrawal.
Observers are now watching whether other journals will follow suit with similar studies that have been used to question vaccine efficacy during the pandemic. The case also raises questions about how peer-reviewed research can be misused in public debates before corrections or retractions occur.
